Medicare

Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Amplitude, Inc.

Retrieved on: 
Friday, April 12, 2024

Kessler Topaz Meltzer & Check, LLP encourages Amplitude investors who have suffered significant losses to contact the firm directly to acquire more information.

Key Points: 
  • Kessler Topaz Meltzer & Check, LLP encourages Amplitude investors who have suffered significant losses to contact the firm directly to acquire more information.
  • A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

MEDIA ADVISORY: Press conferences with patients who have been charged user fees of hundreds or even thousands of dollars at for-profit surgery clinics

Retrieved on: 
Friday, April 12, 2024

The extra charges for medically necessary services are not only unlawful and illegal under Ontario's and Canada's Public Medicare protection laws, but they impose significant financial strain on patients.

Key Points: 
  • The extra charges for medically necessary services are not only unlawful and illegal under Ontario's and Canada's Public Medicare protection laws, but they impose significant financial strain on patients.
  • Patients will join press conferences in four cities to tell their stories.
  • At the same time, the Ontario Health Coalition will release a report based on eighteen case studies and over 100 patients who have reported being charged out-of-pocket fees at for-profit clinics recently.
  • More press conferences in additional communities will follow.

Intermountain McKay Dee Hospital and Intermountain Medical Center Named to Fortune's 2024 Top 50 Heart Hospitals List

Retrieved on: 
Friday, April 12, 2024

SALT LAKE CITY and OGDEN, Utah, April 12, 2024 (GLOBE NEWSWIRE) -- Two Intermountain Health facilities have been named 2024 Top 50 Heart Hospitals in the U.S. by Fortune Magazine.

Key Points: 
  • SALT LAKE CITY and OGDEN, Utah, April 12, 2024 (GLOBE NEWSWIRE) -- Two Intermountain Health facilities have been named 2024 Top 50 Heart Hospitals in the U.S. by Fortune Magazine.
  • Intermountain McKay-Dee Hospital in Ogden, Utah and Intermountain Medical Center in Murray are ranked as two of the nation’s Top 50 Cardiovascular Hospitals for 2024 by Fortune and Pinc AI, which evaluates heart hospitals annually to determine facilities that are excelling in providing high quality, affordable heart care.
  • The Fortune and Pinc AI rankings including teaching hospitals with and without cardiovascular residency programs, along with community hospitals.
  • This is the fourth time in a row that Intermountain Medical Center has been named to the Fortune Top 50 list, and the first year for Intermountain McKay-Dee Hospital.

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

Retrieved on: 
Friday, April 12, 2024

As previously announced, CMS approved use of Healthcare Common Procedure Coding System Code K1007 to bill Medicare for the Ekso Indego Personal.

Key Points: 
  • As previously announced, CMS approved use of Healthcare Common Procedure Coding System Code K1007 to bill Medicare for the Ekso Indego Personal.
  • This code can also be used by other public health insurance programs as well as private payers.
  • Ekso Bionics will work with inpatient and outpatient clinics across the country to qualify individuals with spinal cord injuries who can potentially benefit from the Ekso Indego Personal.
  • Ekso Bionics has worked with many of these facilities by offering clinical demonstrations, where interested individuals can trial the Ekso Indego Personal.

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Retrieved on: 
Friday, April 12, 2024

CMS states that it calculated this final payment amount by averaging pricing information for exoskeleton devices from Lifeward and other manufacturers.

Key Points: 
  • CMS states that it calculated this final payment amount by averaging pricing information for exoskeleton devices from Lifeward and other manufacturers.
  • “This CMS publication finalizes the payment rate for the ReWalk Personal Exoskeleton for 2024, which importantly concludes all open items related to establishing Medicare benefit category assignment, coding, and reimbursement,” said Larry Jasinski, CEO of Lifeward.
  • The final payment rate is in effective for Medicare claims with dates of service on or after April 1, 2024.
  • To learn more about Medicare reimbursement for Lifeward’s ReWalk Personal Exoskeleton, please visit GoLifeward.com/Medicare.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGL

Retrieved on: 
Friday, April 12, 2024

WHAT TO DO NEXT: To join the agilon class action, go to https://rosenlegal.com/submit-form/?case_id=23637 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the agilon class action, go to https://rosenlegal.com/submit-form/?case_id=23637 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Thursday, April 11, 2024

LOS ANGELES, April 11, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN ) for violations of the securities laws.

Key Points: 
  • LOS ANGELES, April 11, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • Regeneron is the subject of a DOJ lawsuit filed on April 10, 2024.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Medical Guardian Acquires MobileHelp, Expanding Senior Health Care Solutions

Retrieved on: 
Wednesday, May 1, 2024

Medical Guardian today announced that it has acquired MobileHelp from Advocate Aurora Enterprises to broaden its suite of health care solutions supporting aging adults with living independently and safely.

Key Points: 
  • Medical Guardian today announced that it has acquired MobileHelp from Advocate Aurora Enterprises to broaden its suite of health care solutions supporting aging adults with living independently and safely.
  • The strategic acquisition bolsters Medical Guardian’s safety, engagement and wellness capabilities provided to more than 600,000 active members through its personal emergency response systems (PERS), remote patient monitoring (RPM) and health care engagement services.
  • View the full release here: https://www.businesswire.com/news/home/20240501808758/en/
    Medical Guardian Acquires MobileHelp, Expanding Nationwide Access to Comprehensive Senior Health Care Technologies Such as Personal Emergency Response Systems (PERS) and Remote Patient Monitoring (RPM) for Over 600,000 Active Members.
  • (Graphic: Business Wire)
    With MobileHelp, Medical Guardian solidifies its leadership position in supporting members across all market segments, including direct-to-consumer health care, Medicaid, Medicare Advantage, senior living, home care, and health system programs.

Wipro to Implement Independent Health’s Medicare Prescription Payment Plan Platform

Retrieved on: 
Thursday, May 2, 2024

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced they have been selected by Independent Health, Western New York’s only 5-Star Rated Medicare Advantage Plan, to implement Wipro’s Medicare Prescription Payment Plan (MPPP360) platform for the upcoming open enrollment period.

Key Points: 
  • Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced they have been selected by Independent Health, Western New York’s only 5-Star Rated Medicare Advantage Plan, to implement Wipro’s Medicare Prescription Payment Plan (MPPP360) platform for the upcoming open enrollment period.
  • Starting in 2025, the Medicare Prescription Payment Plan will allow enrollees to make capped monthly payments for out-of-pocket prescription drugs, amongst other changes.
  • Wipro’s MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions, simplifying prescription cost management for Medicare recipients in Western New York.
  • Narayan Iyer, Vice President, Healthcare, Wipro Limited, said “We are excited to introduce our Medicare Prescription Payment Plan360 platform, better known as MPPP360, to Western New York.

SelectQuote to Release Fiscal Third Quarter 2024 Earnings on May 9; Will Present at RBC’s Global Healthcare Conference on May 15

Retrieved on: 
Wednesday, May 1, 2024

SelectQuote will release its fiscal third quarter 2024 financial results before market open on Thursday, May 9, 2024.

Key Points: 
  • SelectQuote will release its fiscal third quarter 2024 financial results before market open on Thursday, May 9, 2024.
  • Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 9, 2024) at 9:00 am ET to discuss the results.
  • To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=2a79382d&confId=63927
    After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry.
  • Tim Danker, Chief Executive Officer, Ryan Clement, Chief Financial Officer, and Bob Grant, President, will participate in a fireside chat at RBC’s Global Healthcare Conference in New York on May 15, 2024, beginning at approximately 9:00 am ET.